Insider Trades
News
newsfilecorp.comKiora Pharmaceuticals Reports its Ion Channel Modulator, KIO-300, Suppressed Seizure Activity in Preclinical Epilepsy Modelnewsfilecorp.comJun 18
newsfilecorp.comKiora Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Updatenewsfilecorp.comMay 8
newsfilecorp.comKiora's Phase 1 ABACUS Study of KIO-301 in Retinitis Pigmentosa Published in Nature Medicine; Phase 2 Trial Underwaynewsfilecorp.comApr 14
defenseworld.netFinancial Comparison: Cronos Group (NASDAQ:CRON) & Kiora Pharmaceuticals (NASDAQ:KPRX)defenseworld.netApr 14
newsfilecorp.comKiora Pharmaceuticals Announces Management Team Changesnewsfilecorp.comApr 2